PDF(1093 KB)
Clinical application of whole exome sequencing in monogenic hereditary disorders in critically ill newborns
QI Zhi-Ye, DUAN Jiang, HE Xiang-Ying, ZHONG Qing-Hua, ZHANG Cai-Ying, XIE Yun-Bo, LIANG Kun
Chinese Journal of Contemporary Pediatrics ›› 2019, Vol. 21 ›› Issue (7) : 640-643.
PDF(1093 KB)
PDF(1093 KB)
Clinical application of whole exome sequencing in monogenic hereditary disorders in critically ill newborns
Objective To explore the value and significance of the clinical application of whole exome sequencing (WES) in monogenic hereditary disorders in critically ill newborns. Methods The critically ill newborns in the neonatal intensive care unit with suspected hereditary diseases or unclear clinical diagnosis from June 2016 to December 2018 were enrolled. The whole blood samples from both newborns and parents were collected for WES. The detected genetic mutations were classified, the mutations associated with clinical phenotypes were searched for, and Sanger sequencing was performed to verify the mutations. Results A total of 45 newborns were enrolled, including 22 males and 23 females, and the median age of onset was 2.0 days. Of the 45 newborns, 12 (27%) were confirmed with monogenic hereditary disorders by molecular diagnostics, and the median age at diagnosis was 31.5 days. Of the 12 newborns with monogenic hereditary disorders, 5 (42%) were partially associated with clinical phenotypes but confirmed with monogenic hereditary disorders by additional information supplement and analysis. The improvement rate of newborns with monogenic hereditary disorders was 67% (8/12) after treatment. Conclusions WES technology is a powerful tool for finding genetic mutations in monogenic hereditary disorders in critically ill newborns and can play a crucial role in clinical decision-making. However, a comprehensive interpretation of sequence data requires physicians to take the clinical phenotypes and the results of WES into consideration simultaneously.
Monogenic hereditary disorder / Whole exome sequencing / Newborn
[1] 孙丽雅, 邢清和, 贺林. 中国出生缺陷遗传学研究的回顾与展望[J]. 遗传, 2018, 40(10):800-813.
[2] 王慧君, 周文浩. 精准医疗时代新生儿遗传病临床干预面临的机遇与挑战[J]. 中华儿科杂志, 2018, 56(4):244-246.
[3] 吴怡, 程蔚蔚. 出生缺陷概况及产前筛查[J]. 中国计划生育和妇产科, 2016, 8(1):29-33, 52.
[4] Smith LD, Willig LK, Kingsmore SF. Whole-exome sequencing and whole-genome sequencing in critically ill neonates suspected to have single-gene disorders[J]. Cold Spring Harb Perspect Med, 2015, 6(2):a023168.
[5] 中华医学会急诊学分会儿科学组, 中华医学会儿科学分会急诊学组、新生儿学组. 新生儿危重病例评分法(草案)[J]. 中华儿科杂志, 2001, 39(1):42-43.
[6] Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-424.
[7] 黎籽秀, 刘博, 徐凌丽, 等. 高通量测序数据分析和临床诊断流程的解读[J]. 中国循证儿科杂志, 2015, 10(1):19-24.
[8] 杨琳, 董欣然, 彭小敏, 等. 复旦大学附属儿科医院高通量测序数据分析流程(第二版)对遗传疾病候选变异基因筛选用时和准确性分析[J]. 中国循证儿科杂志, 2018, 13(2):118-123.
[9] 姜烈君, 陆晓旭, 黄华艺. 下一代测序技术的临床应用规范化问题-参考美国医学遗传学与基因组学会行业标准[J]. 分子诊断与治疗杂志, 2016, 8(4):217-221.
[10] Choi M, Scholl UI, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing[J]. Proc Natl Acad Sci U S A, 2009, 106(45):19096-19101.
[11] 饶书权, 杜廷福, 许琪. 外显子组测序在人类疾病中的应用[J]. 遗传, 2014, 36(11):1077-1086.
[12] Wright CF, FitzPatrick DR, Firth HV. Paediatric genomics:diagnosing rare disease in children[J]. Nat Rev Genet, 2018, 19(5):253-268.
[13] Meng L, Pammi M, Saronwala A, et al. Use of exome sequencing for infants in intensive care units:ascertainment of severe single-gene disorders and effect on medical management[J]. JAMA Pediatr, 2017, 171(12):e173438.
[14] Miller NA, Farrow EG, Gibson M, et al. A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases[J]. Genome Med, 2015, 7:100.
[15] Salmon LB, Orenstein N, Markus-Bustani K, et al. Improved diagnostics by exome sequencing following raw data reevaluation by clinical geneticists involved in the medical care of the individuals tested[J]. Genet Med, 2019, 21(6):1443-1451.
